Cargando…
Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells
Glioblastoma is the most common form of primary malignant brain tumour. These tumours are highly proliferative and infiltrative resulting in a median patient survival of only 14 months from diagnosis. The current treatment regimens are ineffective against the small population of cancer stem cells re...
Autores principales: | Siney, Elodie J., Holden, Alexander, Casselden, Elizabeth, Bulstrode, Harry, Thomas, Gareth J., Willaime-Morawek, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443867/ https://www.ncbi.nlm.nih.gov/pubmed/27541285 http://dx.doi.org/10.1007/s12035-016-0053-6 |
Ejemplares similares
-
The ADAM metalloproteinases
por: Edwards, Dylan R., et al.
Publicado: (2008) -
The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016) -
Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017) -
Immunomodulatory role of metalloproteinase ADAM17 in tumor development
por: Wang, Kai, et al.
Publicado: (2022) -
Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17
por: Yang, Guang, et al.
Publicado: (2021)